Observational Study - ILM Peeling

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
M. Dominik Fischer, University Hospital Tuebingen
ClinicalTrials.gov Identifier:
NCT01083056
First received: March 8, 2010
Last updated: July 30, 2014
Last verified: July 2014
  Purpose

This observational study investigates the effects of epimacular membrane peeling on the structure and function of the retina.


Condition
Epimacular Gliosis
Macular Hole

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Observational Study On Retinal Structure And Function Before And After Epimacular Membrane Peeling

Further study details as provided by University Hospital Tuebingen:

Primary Outcome Measures:
  • BCVA [ Time Frame: 6 months after ILM peeling ] [ Designated as safety issue: No ]

Enrollment: 10
Study Start Date: March 2010
Study Completion Date: July 2014
Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts
Epimacular Gliosis Without Macular Hole
Epimacular Gliosis With Macular Hole

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Inpatients at the University Eye Hospital Tuebingen

Criteria

Inclusion Criteria:

  • Clinical diagnosis of Epimacular Gliosis
  • Must be scheduled for ILM-peeling independently of study
  • Must be older then 18 years of age

Exclusion Criteria:

  • Visual acuity > 0,4 logMAR (< 20/50 EDTRS)
  • Other ophthalmological disorder affecting visual acuity and/or visual field and/or retinal structure
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01083056

Locations
Germany
Centre for Ophthalmology, University Hospital Tuebingen
Tuebingen, BW, Germany, 72076
Sponsors and Collaborators
University Hospital Tuebingen
Investigators
Principal Investigator: Florian Gekeler, MD Centre for Ophthalmology, University Hospital Tuebingen
  More Information

No publications provided

Responsible Party: M. Dominik Fischer, PD Dr. med. M. Dominik Fischer, University Hospital Tuebingen
ClinicalTrials.gov Identifier: NCT01083056     History of Changes
Other Study ID Numbers: ILM Peeling
Study First Received: March 8, 2010
Last Updated: July 30, 2014
Health Authority: Germany: Ministry of Health

Keywords provided by University Hospital Tuebingen:
retina
gliosis
macula
membrane
ILM

Additional relevant MeSH terms:
Gliosis
Pathologic Processes

ClinicalTrials.gov processed this record on October 23, 2014